Log In
BCIQ
Print this Print this
 

MI-100

  Manage Alerts
Collapse Summary General Information
Company Makindus Inc.
DescriptionUndisclosed
Molecular Target Cholinesterase
Mechanism of ActionCholinesterase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat Stargardt's disease
Regulatory Designation U.S. - Orphan Drug (Treat Stargardt's disease)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today